| 1 |
Crystal violet with cadmium-free quantum dots |
Swell-encapsulation-shrink method, incorporation into polyurethane |
methicillin-resistant Staphylococcus aureus: 99.98% reduction. E. coli: 99.96% reduction |
18 h for S. Aureus and 4 h for E. Coli; broad-band visible illumination at 6000 lux |
169
|
| 2 |
Crystal violet, ZnO nanoparticles |
Two step dipping process, incorporation in acrylic latex |
E. coli: 1.97–2.51 log reduction for CV-only (4 h). S. aureus: 1.16–2.01 log reduction for CV-only (3 h, 1.34 log higher for CV-ZNO) |
2 h-6 h, white light, 512 lux |
170
|
| 3 |
Phloxine B, layered silicate, polyurethane |
Nanocomposite supported on polytetrafluoroethylene |
S. aureus: 4 log reduction |
120 s irradiation with green laser (532 nm, 100 mW) |
171
|
| 4 |
Erythrosine B, layered silicate, polyurethane |
Nanocomposite supported on polytetrafluoroethylene |
S. aureus: Up to 10.000-fold reduction |
10 min green laser 1.5 h green LED light |
172
|
| 5 |
Methylene blue, crystal violet, Au nanoparticles |
Silicone surface modification |
S. epidermidis: ≥2.92 log reduction (3h). S. cerevisiae: 1.5 log reduction (3 h). MS2 Bacteriophage: 2.33 log reduction (4 h) |
1 h – 5 days, fluorescent tube light, 8 W, 3500 lux |
173
|
| 6 |
Protoporphyrin IX (PPIX-ED), Ag nanoparticles |
(1) Bio-inspired cationic polymer bearing pendent catechols; (2) silver-loaded nanogel decorated with o-quinone groups; (3) amino modified protoporphyrin IX |
B. subtilis: 14.0 mm of inhibition zone. E. coli: 17.4 mm of inhibition zone |
24 h, 380 – 750 nm, 300 W |
174
|
| 7 |
Poly(3,4-ethylenedioxythiophene)-fullerene C60 (PEDOT-fullerene C60) |
Electrochemical polymerization |
S. aureus: >99.9% inactivation |
15, 30, or 60 min, visible light (3.1 mW cm−2, 5.6 J cm−2); different light doses compared to previous studies |
175
|
| 8 |
Porphyrin-fullerene C60 dyad (TCP-C60) |
Electrodeposited film |
S. aureus: 4 log reduction. E. coli: 4 log reduction |
30 min (S. aureus) 60 min (E. coli), 350–800 nm, 90 mW cm−2
|
176
|